Biocytogen Pharms (Beijing) historical data
| Date | Open | High | Low | Close | Adj. close | Volume |
|---|---|---|---|---|---|---|
| 2025-02-06 | 7.700 | 7.820 | 7.600 | 7.690 | 7.690 | 62,000 |
| 2025-02-05 | 7.760 | 7.770 | 7.600 | 7.600 | 7.600 | 38,000 |
| 2025-02-04 | 8.000 | 8.000 | 7.570 | 7.760 | 7.760 | 47,000 |
| 2025-02-03 | 8.000 | 8.200 | 7.600 | 7.910 | 7.910 | 44,500 |
| 2025-01-28 | 7.870 | 7.870 | 7.870 | 7.870 | 7.870 | 138,500 |
| 2025-01-27 | 7.250 | 7.880 | 7.250 | 7.570 | 7.570 | 117,000 |
| 2025-01-24 | 8.000 | 8.200 | 7.500 | 7.880 | 7.880 | 214,500 |
| 2025-01-23 | 8.200 | 8.200 | 7.770 | 7.900 | 7.900 | 50,000 |
| 2025-01-22 | 7.790 | 7.820 | 7.430 | 7.800 | 7.800 | 64,500 |
| 2025-01-21 | 7.500 | 7.870 | 7.450 | 7.790 | 7.790 | 118,500 |
| 2025-01-20 | 7.560 | 7.990 | 7.490 | 7.500 | 7.500 | 73,000 |
| 2025-01-17 | 7.850 | 7.900 | 7.080 | 7.560 | 7.560 | 93,000 |
| 2025-01-16 | 8.000 | 8.030 | 7.540 | 7.540 | 7.540 | 54,000 |
| 2025-01-15 | 8.100 | 8.270 | 7.620 | 8.030 | 8.030 | 28,500 |
| 2025-01-14 | 7.700 | 8.060 | 7.650 | 8.060 | 8.060 | 28,500 |
| 2025-01-13 | 7.520 | 7.690 | 7.450 | 7.690 | 7.690 | 22,500 |
| 2025-01-10 | 7.460 | 7.700 | 7.460 | 7.700 | 7.700 | 32,000 |
| 2025-01-09 | 7.400 | 7.490 | 7.160 | 7.460 | 7.460 | 45,000 |
| 2025-01-08 | 7.590 | 7.590 | 7.070 | 7.530 | 7.530 | 17,500 |
| 2025-01-07 | 7.800 | 7.800 | 7.340 | 7.550 | 7.550 | 40,500 |
| 2025-01-06 | 7.800 | 7.980 | 7.520 | 7.660 | 7.660 | 27,500 |
| 2025-01-03 | 8.120 | 8.390 | 7.800 | 8.110 | 8.110 | 32,500 |
| 2025-01-02 | 8.490 | 8.500 | 8.300 | 8.300 | 8.300 | 17,000 |
| 2024-12-31 | 8.420 | 8.420 | 8.420 | 8.420 | 8.420 | 178,000 |
| 2024-12-30 | 8.600 | 8.600 | 8.000 | 8.400 | 8.400 | 83,000 |
| 2024-12-27 | 8.540 | 8.550 | 8.260 | 8.450 | 8.450 | 51,000 |
| 2024-12-24 | 8.550 | 8.550 | 8.550 | 8.550 | 8.550 | 51,500 |
| 2024-12-23 | 8.450 | 8.500 | 8.110 | 8.470 | 8.470 | 61,500 |
| 2024-12-20 | 8.380 | 8.520 | 8.040 | 8.420 | 8.420 | 61,000 |
| 2024-12-19 | 8.500 | 8.520 | 8.380 | 8.380 | 8.380 | 46,000 |
| 2024-12-18 | 8.500 | 8.500 | 8.110 | 8.400 | 8.400 | 57,000 |
| 2024-12-17 | 8.400 | 8.400 | 7.750 | 7.750 | 7.750 | 58,000 |
| 2024-12-16 | 8.000 | 8.420 | 7.600 | 8.100 | 8.100 | 134,000 |
| 2024-12-13 | 7.600 | 8.120 | 7.310 | 7.930 | 7.930 | 145,500 |
| 2024-12-12 | 7.510 | 7.590 | 7.250 | 7.400 | 7.400 | 205,000 |
| 2024-12-11 | 6.800 | 7.580 | 6.800 | 7.500 | 7.500 | 187,500 |
| 2024-12-10 | 6.610 | 7.190 | 6.600 | 6.720 | 6.720 | 164,500 |
| 2024-12-09 | 6.050 | 6.800 | 6.000 | 6.610 | 6.610 | 140,000 |
| 2024-12-06 | 6.000 | 6.200 | 5.900 | 6.110 | 6.110 | 172,000 |
| 2024-12-05 | 5.800 | 6.150 | 5.800 | 6.100 | 6.100 | 247,000 |
| 2024-12-04 | 5.800 | 5.990 | 5.780 | 5.780 | 5.780 | 157,880 |
| 2024-12-03 | 5.900 | 5.920 | 5.800 | 5.900 | 5.900 | 120,500 |
| 2024-12-02 | 5.800 | 5.990 | 5.800 | 5.840 | 5.840 | 757,500 |
| 2024-11-29 | 5.850 | 6.000 | 5.810 | 5.840 | 5.840 | 110,500 |
| 2024-11-28 | 5.730 | 5.900 | 5.730 | 5.760 | 5.760 | 120,500 |
| 2024-11-27 | 5.900 | 6.000 | 5.700 | 5.730 | 5.730 | 113,000 |
| 2024-11-26 | 5.900 | 6.030 | 5.810 | 5.900 | 5.900 | 135,500 |
| 2024-11-25 | 5.830 | 6.080 | 5.740 | 5.890 | 5.890 | 123,500 |
| 2024-11-22 | 5.860 | 5.870 | 5.670 | 5.670 | 5.670 | 131,500 |
| 2024-11-21 | 6.390 | 6.390 | 5.770 | 6.000 | 6.000 | 106,500 |
| 2024-11-20 | 5.900 | 6.260 | 5.900 | 6.000 | 6.000 | 155,000 |
| 2024-11-19 | 6.000 | 6.400 | 5.820 | 6.000 | 6.000 | 162,500 |
| 2024-11-18 | 6.550 | 6.550 | 5.650 | 6.000 | 6.000 | 146,500 |
| 2024-11-15 | 6.100 | 6.100 | 5.690 | 6.100 | 6.100 | 177,500 |
| 2024-11-14 | 5.800 | 5.900 | 5.600 | 5.600 | 5.600 | 162,500 |
| 2024-11-13 | 5.950 | 5.980 | 5.760 | 5.760 | 5.760 | 143,500 |
| 2024-11-12 | 6.100 | 6.170 | 5.890 | 5.990 | 5.990 | 219,500 |
| 2024-11-11 | 6.000 | 6.110 | 5.920 | 6.060 | 6.060 | 143,500 |
| 2024-11-08 | 6.080 | 6.160 | 5.920 | 6.010 | 6.010 | 197,000 |
| 2024-11-07 | 7.000 | 7.000 | 5.940 | 6.160 | 6.160 | 130,000 |
Stock splits
No stock splits on record.
Dividends
No dividends on record.
Open, high, low and close are as traded (HKD). Adjusted close accounts for splits and dividends. Educational only, not financial advice.